At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD, from Hannover Medical School, Hannover, Germany, reviews ongoing clinical trials for the treatment of patients with metastatic renal cell carcinoma, including investigations of nivolumab versus everolimus; cabozantinib versus everolimus; and lenvatinib combined with everolimus.
Improving the treatment of advanced renal cell carcinoma
14th June 2016
Oncology
Please rate the quality of this content
We are sorry that this content was not interesting for you!
Let us improve this content!
Tell us how we can improve this content?